Source: ERS Satellite 2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Stephen Holgate (UK) & Chirs Brightling (UK). Live from London: Current and future biomarkers in severe asthma. ERS Satellite 2018

Member's Comments

No comment yet.

Related content which might interest you: Live from Rome: Definition, epidemiology and impact of severe asthma Source: ERS Satellite 2018 Year: 2018 Monitoring asthma in children: clinical tools Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014 Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013 Biomarkers for the management of severe asthma: a survey Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Current opinion: Pharmacological approaches in asthma and COPD Source: Breathe 2009; 6: 24-35 Year: 2009 New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012 Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Live from Stockholm: What is different about severe asthma in children and adults? Source: ERS Satellite 2018 Year: 2018 Digital Therapy in the treatment of asthma and COPD - Epidemiology of development and use of an emerging health technology in Respiratory Medicine Source: International Congress 2019 – M-health/e-health II Year: 2019 Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015 Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019 Year: 2020 New frontiers in the management of asthma Source: International Congress 2017 – State of the art session: "Paediatric" Year: 2017 Modeling future COPD epidemiology Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Paradoxical response to bronchodilators: Radiologic correlates and clinical implications Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 International perspectives on severe asthma: Current and future challenges in patient care Source: International Congress 2016 – Asthma points to ponder Year: 2016 Live from Brussels: Pathogenesis of severe asthma and its natural history Source: ERS Satellite 2018 Year: 2018 Recommended new therapies for severe asthma and the future Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop Year: 2014 What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018